Clinical Trial Update: A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

View source ↗

Summary

A multicenter prospective study is evaluating the prognostic value of PSMA PET imaging in patients with newly diagnosed, treatment-naïve prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Xijing Hospital | Conditions: Newly Diagnosed, Treatment-naïve Prostate Cancer | Status: RECRUITING